JPRN-jRCTs052230082招募中Unknown
Safety Evaluation of Hippocampal Stimulation Targeting Sharp Wave Ripple
Yanagisawa Takufumi Takufumi0 个研究点目标入组 4 人开始时间: 2023年8月1日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 4
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 < 80age old（—）
- 性别
- All
入选标准
- •Primary Registration
- •(1) Patients who have had electrodes implanted around the hippocampus during preoperative examinations for epilepsy.
- •(2) Patients who are between 18 and 80 years of age at the time of consent.
- •(3) Patients who have given written consent to participate in this study from themselves or their representative.
- •(4) Those who score 22 or higher on the MMSE.
- •Secondary enrollment
- •(5) Those with a correct response rate of 60% or higher on the 60 Sternberg working memory tasks with a load of 3 or higher.
排除标准
- •Primary Registration
- •(1) Patients who are considered incapable of performing the task due to severe higher-order functional disabilities.
- •(2) Patients who are judged by the principal investigator or sub-investigator to be inappropriate as research subjects for other reasons.
- •Secondary registration
- •Not particularly.
研究者
相似试验
招募中
不适用
Safety evaluation and therapeutic effect analysis of knee hyperthermia with resonant cavity applicatorJPRN-UMIN000033721nternational University of Health and Welfare20
尚未招募
不适用
An evaluation study on the effectiveness and safety of thermal and massage device interventions on pain reduction and postural alignment in patients with low back paiDiseases of the musculoskeletal system and connective tissueKCT0008212Korea University21
进行中（未招募）
1 期
Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to AssessAdverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) Solid TumorsAdvanced Solid Tumors Cancer, Non Small Cell Lung Cancer (NSCLC)JPRN-jRCT2031210468Yajima Yoko109
进行中（未招募）
1 期
Study to evaluate QR-421a in subjects with retinitis pigmentosa (RP) due to mutations in exon 13 of the USH2A GeneEUCTR2018-002433-38-FRProQR Therapeutics18
已完成
不适用
Clinical pharmacological study for safety evaluation of ephedrine alkaloids-free Ephedra Herb extract (EFE) in healthy volunteersthose who are adapted Kampo formula which include Ephedra HerbJPRN-UMIN000022061Clinical Trial Center, Kitasato University Hospital12